HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bjorn Gudbjornsson Selected Research

rofecoxib (Vioxx)

6/2010Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bjorn Gudbjornsson Research Topics

Disease

20Psoriatic Arthritis
04/2024 - 11/2014
15Rheumatoid Arthritis
03/2024 - 01/2017
10Axial Spondyloarthritis
01/2024 - 01/2020
9Pain (Aches)
01/2024 - 12/2016
8Ankylosing Spondylitis
09/2023 - 05/2010
7Fatigue
01/2024 - 01/2018
4Arthritis (Polyarthritis)
02/2023 - 09/2013
3Necrosis
01/2023 - 01/2021
2Osteoporosis
01/2024 - 01/2002
2Rheumatic Diseases (Rheumatism)
02/2023 - 01/2017
2Neoplasms (Cancer)
12/2022 - 01/2021
2Inflammation (Inflammations)
01/2022 - 01/2022
2Joint Diseases (Joint Disease)
01/2020 - 09/2013
1Infections
01/2023
1Multiple Sclerosis
01/2023
1Demyelinating Diseases (Demyelinating Disease)
01/2023
1Polyneuropathies (Polyneuropathy)
01/2023
1Non-Radiographic Axial Spondyloarthritis
01/2023
1Spondylarthritis (Spinal Arthritis)
11/2022
1Autoimmune Hepatitis
01/2022
1Acute Coronary Syndrome
01/2022
1Chemical and Drug Induced Liver Injury
01/2022
1COVID-19
01/2021
1Hypoxia (Hypoxemia)
01/2021
1Reactive Arthritis (Reiter Disease)
10/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020
1Thyroid Diseases (Thyroid Disease)
01/2020
1Premature Birth (Birth, Premature)
01/2019
1Gouty Arthritis
04/2018
1Body Weight (Weight, Body)
11/2014
1Cerebral Infarction
06/2010
1Myocardial Infarction
06/2010
1Unstable Angina
06/2010

Drug/Important Bio-Agent (IBA)

19Tumor Necrosis Factor InhibitorsIBA
04/2024 - 01/2019
11Antirheumatic Agents (DMARD)IBA
03/2024 - 01/2017
7secukinumabIBA
01/2024 - 01/2020
6C-Reactive ProteinIBA
09/2023 - 01/2018
5ametantrone (HAQ)IBA
01/2024 - 01/2019
4Methotrexate (Mexate)FDA LinkGeneric
10/2023 - 12/2020
4Abatacept (Orencia)FDA Link
10/2023 - 12/2020
4Infliximab (Remicade)FDA Link
01/2022 - 11/2014
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2024 - 01/2002
3Etanercept (Enbrel)FDA Link
01/2023 - 01/2018
3Adalimumab (Humira)FDA Link
01/2023 - 01/2018
3amsonic acid (DAS)IBA
01/2020 - 12/2016
2Prostaglandins AIBA
01/2024 - 11/2022
2GlucocorticoidsIBA
01/2024 - 01/2017
2Certolizumab PegolFDA Link
10/2023 - 10/2022
2tocilizumab (atlizumab)FDA Link
10/2023 - 10/2022
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022 - 02/2022
2ORALIT (ORS)IBA
01/2022 - 01/2021
2HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2022 - 05/2010
2Anti-Citrullinated Protein AntibodiesIBA
12/2020 - 01/2020
2Rheumatoid FactorIBA
12/2020 - 01/2020
1ProstaglandinsIBA
03/2024
1SteroidsIBA
01/2024
1AntibodiesIBA
01/2023
1tofacitinibIBA
01/2023
1apremilastIBA
01/2023
1ixekizumabIBA
01/2023
1Ustekinumab (CNTO 1275)FDA Link
01/2023
1insulin receptor-related receptor (IRR)IBA
12/2022
1ChemokinesIBA
07/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1HLA-B Antigens (HLA-B)IBA
07/2021
1Interferon-alpha (Interferon Alfa)IBA
01/2021
1AutoantibodiesIBA
01/2021
1Interferon Type IIBA
01/2021
1flt3 ligand protein (flt3 ligand)IBA
01/2020
1Uric Acid (Urate)IBA
04/2018
1HLA-B14 AntigenIBA
09/2013
1AntigensIBA
09/2013
1HLA-B8 Antigen (HLA B8 Antigen)IBA
09/2013
1HLA Antigens (Human Leukocyte Antigens)IBA
09/2013
1HLA-A11 AntigenIBA
09/2013
1Diclofenac (SR 38)FDA LinkGeneric
06/2010
1Ibuprofen (Motrin)FDA LinkGeneric
06/2010
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2010
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2010
1Naproxen (Naprosyn)FDA LinkGeneric
06/2010
1rofecoxib (Vioxx)FDA Link
06/2010

Therapy/Procedure

5Therapeutics
10/2023 - 01/2002
1Aftercare (After-Treatment)
02/2022
1Cesarean Section (Caesarean Section)
01/2019